PAPER Jia F, Fu L
SEARCH RESULTS
1770 RESULTS
PAPER Nuovo GJ, Rice M, Zanesi N, Sawant D, Crilly C, Tili E
The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2.
Appl Immunohistochem Mol Morphol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.PAPER Arafi P, Devkota S, Williams E, Maesako M, Wolfe MS
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production.
Elife. 2025 Feb 11;13 PubMed.PAPER Stefani A, Antelmi E, Arnaldi D, Arnulf I, During E, Högl B, Hu MM, Iranzo A, Luke R, Peever J, Postuma RB, Videnovic A, Gan-Or Z
From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease.
Mol Neurodegener. 2025 Feb 11;20(1):19. PubMed.PAPER Furusawa-Nishii E, Solongo B, Rai K, Yoshikawa S, Chiba A, Okuzumi A, Ueno SI, Hoshino Y, Imamichi-Tatano Y, Kimura H, Hatano T, Hattori N, Miyake S
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's disease.
J Neuroinflammation. 2025 Feb 11;22(1):38. PubMed.PAPER Otero-Jimenez M, Wojewska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL, Gentleman S, Alegre-Abarrategui J
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. PubMed.PAPER Simitsi AM, Sfikas E, Koros C, Papagiannakis N, Beratis I, Papadimitriou D, Antonellou R, Fragiadaki S, Kontaxopoulou D, Picillo M, Pachi I, Alefanti I, Stamelou M, Barone P, Stefanis L
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study.
J Neurol. 2025 Feb 12;272(3):203. PubMed.PAPER Outeiro TF, Höglinger G, Lang AE, Vieira TC
Protein misfolding: understanding biology to classify and treat synucleinopathies.
J Neural Transm (Vienna). 2025 Feb 11; Epub 2025 Feb 11 PubMed.PAPER Ren J, Xie D, Wang L, Wu Z, Lin S, Jin Q, Luo Y, Zhu B, Huang H, Wang J, Zhang S, Liu Z, Chen G, Luo M, Yang D
Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.
J Neurol. 2025 Feb 11;272(3):196. PubMed.PAPER Zheng C, Zhao W, Yang Z, Guo S, Alzheimer’s Disease Neuroimaging Initiative
Dysfunction in the hierarchy of morphometric similarity network in Alzheimer's disease and its correlation with cognitive performance and gene expression profiles.
Psychol Med. 2025 Feb 12;55:e42. PubMed.PAPER Mengr A, Šmotková Z, Pačesová A, Železná B, Kuneš J, Maletínská L
Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease.
J Neuroimmune Pharmacol. 2025 Feb 11;20(1):18. PubMed.PAPER Pasquini J, Sigurdsson HP, Firbank M, Best L, Foster V, Galley D, Maxwell R, Silani V, Ceravolo R, Petrides G, Brooks DJ, Pavese N
Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy.
J Neurol. 2025 Feb 11;272(3):195. PubMed.PAPER Qiu Y, Zhao Y, He G, Yang D
Porphyromonas gingivalis and Its Outer Membrane Vesicles Induce Neuroinflammation in Mice Through Distinct Mechanisms.
Immun Inflamm Dis. 2025 Feb;13(2):e70135. PubMed.PAPER Feng X, Zhao S
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer's disease.
Front Aging Neurosci. 2025;17:1530046. Epub 2025 Jan 27 PubMed.PAPER Kovalenko EA, Makhnovich EV, Pervunina AV, Gileva EA, Bogolepova AN
[Non-invasive biomarkers for early diagnosis of Alzheimer's disease in bodily fluids].
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(1):8-16. PubMed.Current Filters
- Date Range : Feb 2025 to Mar 2025 x